{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-019594","form_type":"8-K","ticker":"DCGO","cik":"0001822359","company_name":"DocGo Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.800486+00:00","generated_at":"2026-06-18T04:46:05.929351+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DocGo FY2022 revenue $440.5M (+38% YoY); guides 2023 revenue $500-$510M, Adj. EBITDA $45-50M","bullets":["Full-year 2022 revenue $440.5M, up 38% YoY; net income $30.7M (+60%); Adjusted EBITDA $41.3M (+65%).","Q4 revenue $108.8M vs $121.3M (Q4 2021 had $50M COVID revenue); transport revenue up 98% to $37M.","2023 guidance: revenue $500-510M (14-16% as-reported, 36-40% ex-COVID); Adj. EBITDA $45-50M; gross margin ~35%.","Backlog of $180M over three years; 34 active RFPs totaling over $1B; $90M Citibank credit line unused.","Since Jan 2023, awarded over $180M in new business across US and UK, including health system contracts; hiring hundreds, adding 100+ vehicles."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-019594","json":"https://secwatch.observer/filing/0001213900-23-019594.json","markdown":"https://secwatch.observer/filing/0001213900-23-019594.md","text":"https://secwatch.observer/filing/0001213900-23-019594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/ea175098-8k_docgoinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:46:05.929351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0799eb9df8fa504e7c431aa17ef7316571549067","claim":"DocGo Inc. reported the fourth quarter ended December 31, 2022 results: revenue $108.8 million, net income $7.1 million.","evidence_excerpt":"Total Q4 2022 revenue was $108.8 million, which includes approximately $1 million of COVID testing revenue, compared to $121.3 million in Q4 2021","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$108.8 million"},{"label":"Net income","value":"$7.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9dc1f722d1f9530254dc27da3eaf58a5180f75cc","claim":"DocGo Inc. reported the year ended December 31, 2022 results: revenue $440.5 million, net income $30.7 million.","evidence_excerpt":"PRESS RELEASE OF DOCGO INC. DATED MARCH 13, 2023 ANNOUNCING EARNINGS RELEASE Exhibit 99.1 DocGo Announces Fourth Quarter and Full-Year 2022 Results 2022 Revenue Increased to $440.5 Million, Versus $318.7 Million in 2021, an Increase of 38% Full Year Revenue up 75% Year-Over-Year Excluding Mass Covid Testing Company introduces Full-Year 2023 Revenue and Adjusted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$440.5 million"},{"label":"Net income","value":"$30.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c6b8744124e66dbdb97e0db70c42278f0c6deb62","claim":"DocGo Inc. updated its Full-Year 2023 guidance (initiated).","evidence_excerpt":"Company introduces Full-Year 2023 Revenue and Adjusted EBITDA 1 Guidance of $500-$510 million and $45-$50 million, respectively","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full-Year 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}